Peptides
Latest laboratory result 54.46 mg March 22, 2024 · 108.92% of 50 mg label claim · Batch HDEPT23 View
You will save $54.00
Epitalon 50 mg
Product Details Dragon Pharma
Active Substance Epitalon Acetate Also known as Epithalon
Strength 50 mg per vial
Package 1 × 2 mL vial 50 mg labeled content
Form Lyophilized powder
Research Class Synthetic tetrapeptide
Peptide Sequence Ala-Glu-Asp-Gly AEDG · 4 amino acids
Human Half-Life Not established
Development Status Experimental
$81.00
$135.00
Shipping Location :
International
U.S. Domestic
Epitalon 50 mg by Dragon Pharma – Cellular Longevity & Telomere Support
✔ Synthetic longevity peptide ✔ Lyophilized peptide formulation ✔ Telomere-support positioning ✔ Lab-tested potency
Epitalon 50 mg by Dragon Pharma provides 50 mg of Epitalon per 2 mL vial in lyophilized form. This synthetic tetrapeptide is widely discussed in longevity-focused protocols for its potential relationship to telomerase activity, sleep regulation, and broader cellular support.
What is Epitalon?
Epitalon (also spelled Epithalon) is a synthetic peptide modeled after epithalamin, a compound associated with the pineal gland. It is most commonly referenced in anti-aging research due to its proposed role in telomerase activation and support of healthy cellular replication.
Epitalon is often discussed alongside other longevity-focused peptides such as CJC-1295 DAC or Dragontropin in broader recovery and wellness-oriented protocols.
- ✔ Supports longevity-focused peptide protocols
- ✔ Commonly associated with telomere and cellular support
- ✔ Frequently discussed in sleep and recovery contexts
- ✔ Lyophilized format supports storage stability before reconstitution
- ✔ Often used in structured anti-aging peptide stacks
Verified 2024 Batch
Independent testing confirmed 54.46 mg per vial, equal to 108.92% of label claim for batch #HDEPT23.
Technical Details
Peptide Type
Synthetic Tetrapeptide
Peptide Sequence
Ala-Glu-Asp-Gly (AEDG)
Peptide Length
4 Amino Acids
Chemical Form
Epitalon Monoacetate
Molecular Formula
C₁₆H₂₆N₄O₁₁
Molecular Weight
450.40 g/mol
CAS Number
307297-40-1
PubChem CID
146155988
Parent Peptide
Epitalon (Epithalon)
Development Status
Experimental
Dosage & Usage Guidelines
For subcutaneous use after reconstitution. Epitalon is supplied as a lyophilized peptide and must be reconstituted with bacteriostatic water prior to administration.
Administration Profile
- ✔ Lyophilized peptide requiring reconstitution
- ✔ Subcutaneous injection (preferred method)
- ✔ Short active window, often split into multiple injections
After reconstitution, Epitalon is typically administered subcutaneously with rotation of injection sites to minimize irritation. Due to its short activity window, dosing is often divided into multiple administrations per day.
How is Epitalon 50 mg used?
- Standard protocol: 5–10 mg per day
- Administration: often split into 2 injections (AM / PM)
- Cycle duration: 10–20 consecutive days
Epitalon is commonly used in short-duration protocols rather than continuous long-term use.
Cycle Structure
- Duration: 10–20 days
- Frequency: 2–3 cycles per year
- Goal: longevity-focused or recovery-oriented protocols
It is often combined with structured sleep, nutrition, and recovery strategies, and may be included alongside other peptide-based protocols.
Potential Side Effects
- Mild redness or irritation at injection site
- Temporary discomfort after administration
- Limited long-term human data available
Epitalon is generally considered well-tolerated, but due to limited long-term clinical data, individuals with underlying conditions should approach use cautiously.
Post-Cycle Considerations
Epitalon does not suppress endogenous hormone production and does not require post-cycle therapy. When used alongside other suppressive compounds, recovery planning should reflect the full protocol.
Important: Individual response varies. Dosing strategies and overall protocol design should be adjusted based on experience level and tolerance.
Batch-Tested & Verified Lab Results
Independent analytical testing confirms the potency of Epitalon in this lyophilized peptide formulation. The measured result exceeds the labeled content while remaining within expected assay variance for peptide-based compounds.
Test Date
2024-03-22
Batch Number
#HDEPT23
Measured Result
54.46 mg
Assay vs Label
108.92%
COA summary: potency verified, purity passed, heavy metals passed.
COA Verified
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 hours after payment confirmation
Tracking
Tracking number provided after shipment
Direct Manufacturer Supply
This product is supplied through the official Dragon Pharma distribution chain and delivered in original sealed manufacturer packaging. Orders are shipped using discreet outer packaging with no unnecessary product identification.
Lyophilized peptide formulations remain stable during standard shipping conditions prior to reconstitution.
What to Expect
- ✔ Orders are processed after payment confirmation
- ✔ USA Domestic warehouse offers faster delivery when selected
- ✔ International shipping includes tracking (updates may vary by region)
- ✔ Multiple warehouses may result in split shipments if applicable
- ✔ Reshipment support available in case of delivery issues
Authenticity support: official Dragon Pharma presentation, batch-linked lab verification, and original packaging reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Before Reconstitution
Store at room temperature (15–25°C) in a dry place, protected from direct light and excessive heat. Keep vials in their original packaging to preserve stability of the lyophilized peptide.
After Reconstitution
Once reconstituted with bacteriostatic water, store the solution refrigerated at 2–8°C. Do not freeze. Avoid shaking the vial; gently swirl if needed.
Inspect the solution before use. Do not administer if it appears cloudy, discolored, or contains visible particles.
Reconstituted solutions should be used within a reasonable time frame to maintain stability and effectiveness.
Keep out of reach of children. Follow proper sterile handling practices during preparation and administration.
Proper storage conditions help preserve peptide stability and biological activity throughout use.
Frequently Asked Questions
What is the ideal dosage for Epitalon 50mg?
The typical dosage for anti-aging purposes is 5–10 mg per day, administered subcutaneously for 10–20 days. This cycle may be repeated 2–3 times per year.
How does Epitalon work in the body?
Epitalon stimulates telomerase production, which helps maintain the length of telomeres—protective caps on chromosomes—supporting DNA integrity and slowing cellular aging.
Does Epitalon require post-cycle therapy (PCT)?
No, Epitalon does not affect hormonal levels, so traditional PCT is not required. It can be used cyclically without endocrine disruption.
Can Epitalon be stacked with other peptides?
Yes, Epitalon is often stacked with peptides like HGH, CJC-1295, or NAD+ for enhanced anti-aging, recovery, or regenerative effects.
Is Epitalon safe for long-term use?
Epitalon is considered very safe with minimal side effects. Most protocols recommend cycles a few times per year rather than continuous use.
Related Offers
Coming Soon!
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance GHK-Cu Copper tripeptide
Strength 10 mg per vial
Package 1 × 2 mL vial 10 mg labeled content
Form Lyophilized powder
Research Class Copper-binding peptide
Peptide Type Tripeptide Gly-His-Lys · GHK
Human Half-Life Not established
Research Focus Tissue remodeling
Domestic & International
-40% OFF
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance AOD9604 Modified hGH fragment
Strength 5 mg per vial
Package 1 × 2 mL vial 5 mg labeled content
Form Lyophilized powder
Research Class GH-derived peptide
Peptide Fragment hGH 176–191
Human Half-Life Not established
Development Status Investigational
$42.00
$70.00
Lab Tested
Domestic & International
-40% OFF
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Survodutide BI 456906
Strength 10 mg per vial
Package 1 × 2 mL vial 10 mg labeled content
Form Lyophilized powder
Research Class Dual receptor agonist
Receptor Activity GCGR / GLP-1R
Estimated Half-Life ~4.5–5 days
Development Status Investigational
$60.00
$100.00
Lab Tested
Domestic & International
-40% OFF
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Mazdutide Long-acting synthetic peptide
Strength 10 mg per vial
Package 1 × 2 mL vial 10 mg labeled content
Form Lyophilized powder
Drug Class Dual receptor agonist GLP-1R + glucagon receptor
Mechanism GLP-1R / GCGR agonism
Estimated Half-Life Approximately 8 days
Dosing Profile Long-acting Developed for once-weekly administration
$60.00
$100.00
Lab Tested
Domestic & International
-40% OFF
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Cagrilintide Acetate Long-acting amylin analog
Strength 10 mg per vial
Package 1 × 2 mL vial 10 mg labeled content
Form Lyophilized powder
Drug Class Amylin analog
Mechanism Amylin receptor agonist
Estimated Half-Life Approximately 6.6–8.1 days
Development Status Investigational
$60.00
$100.00
November 16, 2024
my body composition improved steadily, and my sleep quality was better than before. I could maintain consistent energy levels, helping me stay focused during workouts.